Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats

Acta Pharmacologica Sinica

Volumn 23, Issue 10, 2002, Pages 871-877

  Zhang, Wei Ping ^a,b   Wei, Er Qing ^a   Mei, Ru Huan ^a   Zhu, Chao Yang ^a   Zhao, Meng Hui ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blood brain barrier; Brain edema; Cerebral arteries; Cerebral ischemia; Leukotriene receptor; ONO 1078

Indexed keywords

ALBUMIN; BRAIN PROTEIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST; SODIUM CHLORIDE; CHROMONE DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN PERFUSION; CELL DENSITY; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; EXUDATE; HEMISPHERE; HIPPOCAMPUS; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION; SCORING SYSTEM; TREATMENT OUTCOME; ANIMAL; BLOOD BRAIN BARRIER; CEREBRAL ARTERY DISEASE; PATHOPHYSIOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CHROMONES; INFARCTION, MIDDLE CEREBRAL ARTERY; LEUKOTRIENE ANTAGONISTS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0036791715     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aktan S, Aykut C, Ercan S. Leukotriene C4 and prostaglandin E2 activities in the serum and cerebrospinal fluid during acute cerebral ischemia. Prostaglandins Leukotrienes Esset Fatty Acids 1991; 43: 247-9.
2. Ciceri P, Rabuffetti M, Monopoli A, Nicosia S. Production of leukotrienes in a model of focal cerebral ischemia in the rat. Br J Pharmacol 2001; 133: 1323-9.
3. 4: role in transient cerebral ischemia of gerbils. Neurochem Res 1999; 24: 1225-32.
4. 4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab 1991; 11: 638-43.
5. Papadopoulos SM, Black KL, Hoff JT. Cerebral edema induced by arachidonic acid: role of leukocytes and 5-lipoxygenase products. Neurosurgery 1989; 25: 369-72.
6. 2 production following different reperfusion periods in rat brain after forebrain ischemia correlated with morphological changes. Prostaglandins Leukotrienes Essent Fatty Acids 1993; 49: 633-41.
7. Dempsey RJ. Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia. J Neurosurg 1996; 85: 112-6.
8. Hamilton A, Faiferman I, Stober P, Watson RM, O'Byrne PM. Pranluakast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol 1998; 102: 177-83.
9. Yoshida S, Sakamoto H, Ishizaki Y, Onuma K, Shoji T, Nakagawa H, et al. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma. Clin Exp Allergy 2000; 30: 64-70.
10. Hirano T. Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis. Scand J Gastroenterol 1997; 32: 84-8.
11. Shirasaki H, Asakura K, Narita S, Kataura A. The effect of a cysteinyl leukotriene antagonist, ONO-1078 (pranlukast) on agonist- and antigen-induced nasal microvascular leakage in guinea pigs. Rhinology 1998; 36: 62-5.
12. Wei EQ, Xin XH, Wang YC, Chen LP, Zhang LF, Bian RL. Effect of ONO-1078, a leukotriene antagonist, on the cardiovascular responses induced by vagal stimulation, capsaicin and substance P in guinea pigs. Acta Pharmacol Sin 1995; 16: 485-8.
13. Wei EQ, Liu JW, Zhang LF, Zhang WP, Bian RL. Effect of ONO-1078, a leukotriene antagonist, on capsaicin- and substance P-induced bronchoconstriction and airway microvascular leakage in guinea pigs. Acta Pharmacol Sin 1996; 17: 209-12.
14. Wei EQ, Wang YC, Chen LP, Tang FD, Bian RL. Effect of a leukotriene antagonist, ONO-1078, on electric stimulation of vagus (ESV)-induced bronchoconstriction and microvascular leakage in guinea pigs. Acta Pharm Sin 1994; 29: 487-91.
15. 4-induced broncho-constriction and airway microvascular leakage in guinea pigs. Chin J Pharmacol Toxicol 1997; 11: 63-5.
16. Kobayashi H, Ide H, Kassell NF, Handa Y, Aradachi H, Findlay JM, et al. Effect of leukotriene antagonist on experimental delayed cerebral vasospasm. Neurosurgery 1992; 31: 550-5.
17. Zeng LH, Zhang WP, Wang RD, Wei EQ. Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice. Acta Pharm Sin 2001; 36: 148-50.
18. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
19. Belayev L, Alonso OF, Busto R, Zhao WZ, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture: Neurological and pathological evaluation of an improved model. Stroke 1996; 27: 1616-22.
20. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993; 24: 117-21.
21. Tatlisumak T, Takano K, Carano RAD, Miller LP, Foster AC, Fisher M. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke 1998; 29: 1952-8.
22. Spinnewyn B, Cornet S, Auguet M, Chabrier PE. Synergistic protective effects of antioxidant and nitric oxide synthesis inhibitor in transient focal ischemia damage. J Cereb Blood Flow Metab 1999; 19: 139-43.
23. Zapater P, Moreno J, Horga JF. Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia. Brain Res 1997; 772: 57-62.
24. Arias RL, Tasse JRP, Bowlby MR. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia. Brain Res 1999; 816: 299-308.
25. Culmsee C, Stumm RK, Schafer MK, Weihe E, Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol 1999; 379: 33-45.